Skip to main content
Gut logoLink to Gut
. 2004 May;53(Suppl 4):iv25–iv27. doi: 10.1136/gut.2003.034280

Diagnostic utility of reflux disease symptoms

M Shaw
PMCID: PMC1867780  PMID: 15082610

Full Text

The Full Text of this article is available as a PDF (100.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carlsson R., Dent J., Bolling-Sternevald E., Johnsson F., Junghard O., Lauritsen K., Riley S., Lundell L. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol. 1998 Oct;33(10):1023–1029. doi: 10.1080/003655298750026697. [DOI] [PubMed] [Google Scholar]
  2. Fass R., Fennerty M. B., Ofman J. J., Gralnek I. M., Johnson C., Camargo E., Sampliner R. E. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology. 1998 Jul;115(1):42–49. doi: 10.1016/s0016-5085(98)70363-4. [DOI] [PubMed] [Google Scholar]
  3. Fass R., Ofman J. J., Gralnek I. M., Johnson C., Camargo E., Sampliner R. E., Fennerty M. B. Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med. 1999 Oct 11;159(18):2161–2168. doi: 10.1001/archinte.159.18.2161. [DOI] [PubMed] [Google Scholar]
  4. Johnsson F., Roth Y., Damgaard Pedersen N. E., Joelsson B. Cimetidine improves GERD symptoms in patients selected by a validated GERD questionnaire. Aliment Pharmacol Ther. 1993 Feb;7(1):81–86. doi: 10.1111/j.1365-2036.1993.tb00073.x. [DOI] [PubMed] [Google Scholar]
  5. Klauser A. G., Schindlbeck N. E., Müller-Lissner S. A. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990 Jan 27;335(8683):205–208. doi: 10.1016/0140-6736(90)90287-f. [DOI] [PubMed] [Google Scholar]
  6. Lind T., Havelund T., Carlsson R., Anker-Hansen O., Glise H., Hernqvist H., Junghard O., Lauritsen K., Lundell L., Pedersen S. A. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol. 1997 Oct;32(10):974–979. doi: 10.3109/00365529709011212. [DOI] [PubMed] [Google Scholar]
  7. Locke G. R., Talley N. J., Weaver A. L., Zinsmeister A. R. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc. 1994 Jun;69(6):539–547. doi: 10.1016/s0025-6196(12)62245-9. [DOI] [PubMed] [Google Scholar]
  8. Shaw M. J., Talley N. J., Beebe T. J., Rockwood T., Carlsson R., Adlis S., Fendrick A. M., Jones R., Dent J., Bytzer P. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol. 2001 Jan;96(1):52–57. doi: 10.1111/j.1572-0241.2001.03451.x. [DOI] [PubMed] [Google Scholar]
  9. Talley N. J., Meineche-Schmidt V., Paré P., Duckworth M., Räisänen P., Pap A., Kordecki H., Schmid V. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther. 1998 Nov;12(11):1055–1065. doi: 10.1046/j.1365-2036.1998.00410.x. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES